Home > Insider Trading > Filing (0001209191-21-008925)

Filing Details

Accession Number:: 0001209191-21-008925
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-09 18:03:37
Reporting Period:: 2021-02-09

Accepted Time:: 2021-02-09 18:03:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1817229	Vor Biopharma Inc.	VOR	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1598549	J. Andrew Schwab	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1753000	5Am Opportunities I, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1753037	5Am Ventures Vi, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1790778	5Am Opportunities I (Gp), Llc	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1829051	5Am Partners Vi, Llc	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-09	3,308,822	$0.00	3,308,822	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	1,414,026	$0.00	4,722,848	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	111,111	$18.00	4,833,959	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	1,414,026	$0.00	1,414,026	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-02-09	444,444	$18.00	1,858,470	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-2 Preferred Stock	Disposition	2021-02-09	45,000,000	$0.00	3,308,822	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	19,230,768	$0.00	1,414,026	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	19,230,768	$0.00	1,414,026	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closingof the Issuer's initial public offering for no additional consideration, on a 13.6 for-one basis, and had no expiration date.
The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VIand may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held directly byVentures VI, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports.
The shares are directly held by 5AM Opportunities I, L.P ("Opportunities LP"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities LP. Andrew J. Schwab and Dr. Kush Parmar are themanaging members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities LP. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownershipof the shares of Common Stock held directly by Opportunities LP, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports.